EN
HI
Summary
As of 19 Oct, 2026, Cohance Lifesciences stock price is ₹464.05. During the trading session, the stock has moved between an intraday low of ₹458.10 and an intraday high of ₹467.35. Over the last 52 weeks, Cohance Lifesciences has traded between ₹266.70 and ₹917.85.
The stock has recorded a trading volume of 7,63,452 shares,. Its Average Traded Price (ATP) is ₹464.24, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 3 @ ₹464.05.
Cohance Lifesciences has an upper circuit limit of ₹556.85 and a lower circuit limit of ₹371.25. The total value traded stands at ₹35.44 CR, and the delivery percentage for the day is 22.46%.
The stock is currently traded with a market lot size of 1. Cohance Lifesciences also offers a dividend yield of 0%.
Cohance Lifesciences Share Price Chart
Cohance Lifesciences Share Key Metrics
Volume
7.63 L
Market Cap
17754.43 CR
LTQ@LTP
3@464.05
ATP
464.24
Var Margin
22.03 %
Circuit Range
371.25-556.85
Delivery %
22.46 %
Value
35.44 CR
ASM/GSM
No
Market Lot
1
Cohance Lifesciences Fundamentals
P/E Ratio
167.1
P/B Ratio
4.61
Div. Yield
0
Sector P/E
40.5
Sector P/B
3.4
Sec. Div. Yield
0.52
Cohance Lifesciences Resistance and Support
Pivot 458.55
Resistance
First Resistance
472.95
Second Resistance
485.95
Third Resistance
500.35
Support
First Support
445.55
Second Support
431.15
Third Support
418.15
Cohance Lifesciences Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Oct 16 2026 | 460.45 | 464.05 | 0.89% | 467.35 | 458.1 |
| Thu Oct 15 2026 | 446.29 | 459.95 | 3.22% | 471.54 | 444.14 |
| Wed Oct 14 2026 | 436.1 | 445.6 | 1.89% | 448.79 | 432.25 |
Cohance Lifesciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-05 | Quarterly Results |
| 2026-05-12 | Audited Results |
| 2026-02-12 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-05-28 | Audited Results |
| 2025-02-12 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
| 2024-08-09 | Quarterly Results |
Cohance Lifesciences News
Cohance Lifesciences Ltd - 543064 - General Upadte
Cohance Lifesciences' API manufacturing facility in Jaggaiahpet, Andhra Pradesh, underwent a USFDA inspection from September 14-19, 2026. The inspection concluded with the issuance of a Form FDA 483 citing five observations. The company is preparing corrective and preventive actions.
Sep 21 2026 11:37:49
Cohance Lifesciences Management
| Name | Position |
|---|---|
| Umang Vohra | Chairman |
| Himanshu Agarwal | Whole Time Director |
Cohance Lifesciences Similar Stocks
Granules India Ltd.
825.35
13.40 (1.65%)
Astrazeneca Pharma India Ltd.
5970.50
33.50 (0.56%)
Shilpa Medicare Ltd.
937.60
15.50 (1.68%)
Pfizer Ltd.
3814.00
3.20 (0.08%)
Caplin Point Laboratories Ltd.
2301.30
-0.50 (0.02%)
Molbio Diagnostics Ltd.
1574.40
145.10 (10.15%)
Onesource Specialty Pharma Ltd.
1407.80
-25.40 (1.77%)
Poly Medicure Ltd.
1593.80
10.00 (0.63%)
Eris Lifesciences Ltd.
1144.40
-4.40 (0.38%)
Alembic Pharmaceuticals Ltd.
789.45
-3.20 (0.40%)
Cohance Lifesciences FAQs
The Buying Price of Cohance Lifesciences share is 464.05 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Cohance Lifesciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Cohance Lifesciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Cohance Lifesciences shares is 167.1. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Cohance Lifesciences shares is 4.61. Useful to assess the stock's value relative to its book value.
To assess Cohance Lifesciences’s valuation compare Sector P/E, P/B which are 40.5 & 3.4 with sector averages, along with growth rates and financial metrics.
The Market Cap of Cohance Lifesciences is 17754.43 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Cohance Lifesciences share price is 917.85 & 266.70. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Cohance Lifesciences belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in COHANCE
